Valuation : LifeVantage Corporation

Market Cap 76.79M 66.25M 62.41M 56.86M 106M 7.25B 107M 739M 287M 3.71B 288M 282M 12.18B P/E 2027 *
31.4x
P/E 2028 * 19.5x
Enterprise Value 64.11M 55.31M 52.1M 47.47M 88.73M 6.06B 89.39M 617M 239M 3.1B 241M 235M 10.17B EV / Sales 2027 *
0.39x
EV / Sales 2028 * 0.37x
Free-Float
85.42%
Yield 2027 *
-
Yield 2028 * -
1 day+1.96%
1 week-2.95%
Current month-1.11%
1 month-4.86%
3 months-24.76%
6 months+30.42%
Current year+1.62%
1 week 5.86
Extreme 5.86
6.62
1 month 5.86
Extreme 5.86
6.97
Current year 3.9
Extreme 3.9
11.71
1 year 3.9
Extreme 3.9
14.28
3 years 3.9
Extreme 3.9
27.38
5 years 3.04
Extreme 3.04
27.38
10 years 2.86
Extreme 2.86
27.38
Manager TitleAgeSince
Chief Executive Officer 63 05/08/2026
Director of Finance/CFO 53 25/10/2021
Chief Tech/Sci/R&D Officer - 07/01/2026
Director TitleAgeSince
Director/Board Member 74 01/01/2012
Director/Board Member 67 01/02/2017
Director/Board Member 68 17/02/2022
Date Insider Type Main position Quantity % Market Cap. Importance
06/08/26 Free

Chief Executive Officer

848,765 6.7278%
01/07/26 Tax

Chief Financial Officer

-1,361 0.0108%
01/07/26 Tax

Responsable ventes & marketing

-1,717 0.0136%
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%-2.95%-53.87%-16.64% 76.79M
-0.56%-1.89%+56.39%+106.72% 1,034B
+0.80%+4.25%+55.65%+72.43% 663B
-0.46%+0.70%+22.70%+77.93% 462B
+2.48%-1.90%+32.50%+38.60% 344B
+0.18%+5.42%+27.47%+47.59% 307B
+1.34%+0.05%-0.74%+13.38% 251B
-0.07%+1.37%+56.06%+74.39% 239B
+0.17%+2.18%-17.26%-53.97% 207B
+0.17%+0.47%+32.37%+98.99% 186B
Average +0.62%-1.35%+21.13%+45.94% 369.34B
Weighted average by Cap. +0.30%-0.84%+38.17%+67.87%

Financials

2027 *2028 *
Net sales 165M 143M 134M 123M 229M 15.63B 231M 1.59B 618M 7.99B 621M 608M 26.25B 168M 145M 136M 124M 232M 15.84B 234M 1.61B 626M 8.1B 630M 616M 26.6B
Net income 2.49M 2.15M 2.02M 1.84M 3.44M 235M 3.47M 23.94M 9.29M 120M 9.34M 9.14M 395M 4M 3.45M 3.25M 2.96M 5.53M 378M 5.57M 38.45M 14.92M 193M 15.01M 14.68M 634M
Net Debt -12.68M -10.94M -10.31M -9.39M -17.55M -1.2B -17.69M -122M -47.36M -613M -47.63M -46.58M -2.01B -14.88M -12.84M -12.09M -11.02M -20.59M -1.41B -20.75M -143M -55.56M -719M -55.87M -54.65M -2.36B
Logo LifeVantage Corporation
LifeVantage Corporation is an activation company, which is engage in the identification, research, development, formulation and sale of advanced nutrigenomic activators, dietary supplements, weight management products, pre- and pro-biotics, skin and hair care products, and nootropics. The Company’s line of scientifically validated activators includes the flagship Protandim family of products, TrueScience Liquid Collagen, the newest MindBody GLP-1 System, Activation-supporting nutrients such as Omega, D3+, and the Rise AM & Reset PM System , as well as AXIO nootropic energy drink mixes, the full TrueScience line of skin and hair care products, and Petandim, a pet supplement formulated to combat oxidative stress in dogs. It sells its products in the United States, Mexico, Japan, Australia, Hong Kong, Canada, Thailand, the United Kingdom, the Netherlands, Germany, Taiwan, Austria, Spain, Ireland, Belgium, New Zealand and Singapore.
Employees
216
Date Price Change Volume
03/09/26 $6.260 +2.12% 6,584
02/09/26 $6.130 -1.61% 50,591
01/09/26 $6.230 -1.58% 62,655
31/08/26 $6.330 -0.39% 54,537
28/08/26 $6.355 -1.47% 112,939
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
6.130USD
Average target price
7.500USD
Spread / Average Target
+22.35%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LFVN Stock